Exercise increases plasma concentrations of (R)- and (S)-propranolol

European Journal of Clinical Pharmacology

Volumn 50, Issue 4, 1996, Pages 339-342

  Stoschitzky, K ^a   Schumacher, M ^a   Stark, G ^a   Dimai, H P ^a   Stauber, R ^a   Stoschitzky, P ^a   Krejs, G J ^a   Klein, W ^a   Lindner, W ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Chirality; Enantiomers; Isomers; Propranolol; Stereoselectivity

Indexed keywords

ATENOLOL; PROPRANOLOL;

ADULT; AGED; ARTICLE; CHIRALITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; ENANTIOMER; EXERCISE; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; STEREOSPECIFICITY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD PRESSURE; EXERCISE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MOLECULAR CONFORMATION; PROPRANOLOL; STEREOISOMERISM;

EID: 0029996542     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050119     Document Type: Article

References (18)

1. Howe R, Shanks RG (1966) Optical isomers of propranolol. Nature 210:1336-1338
2. Barrett AM, Cullum VA (1968) The biological properties of the optical enantiomers of propranolol and their effects on cardiac arrhythmias. Br J Pharmacol 34:43-55
3. Stoschitzky K, Lindner W, Rath M, Leitner Ch, Uray G, Zernig G, Moshammer T, Klein W (1989) Stereoselective hemodynamic effects of (R)- and (S)-propranolol in man. Naunyn-Schmiedeberg's Arch Pharmacol 339:474-478
4. Stochitzky K, Egginger G, Zernig G, Klein W, Lindner W (1993) Stereoselective features of (R)- and (S)-atenolol: Clinical pharmacologic, pharmacokinetic, and radioligand binding studies. Chirality 5:15-19
5. Daniell HB, Walle Th, Gaffney TE, Webb JG (1979) Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons. J Pharmacol Exp Ther 208:354-359
6. Russell MP, Webb JG, Walle T, Daniell HB, Privitera PJ, Gaffney TE (1983) Adrenergic nerve-stimulation induced release of propranolol from perfused hindlimb and spleen of the dog and associated changes in postjunctional response. J Pharmacol Exp Ther 226:324-329
7. Street JA, Webb JG, Bright PS, Gaffney TE (1984) Accumulation, subcellular localization and release of propranolol from synaptosomes of rat cerebral cortex. J Pharmacol Exp Ther 229:154-161
8. Bright PS, Gaffney TE, Street JA, Webb JG (1985) Depolarization-induced release of propranolol and atenolol from rat cortical synaptosomes. Br J Pharmacol 84:499-510
9. Webb JG, Street JA, Bagwell EE, Walle Th, Gaffney TE (1988) Stereoselective secretion of atenolol from PC12 cells. J Pharmacol Exp Ther 247:958-964
10. Bagwell EE, Webb JG, Walle Th, Gaffney TE (1989) Stereoselective uptake of atenolol into storage granules isolated from PC12 cells. J Pharmacol Exp Ther 249:476-482
11. Stoschitzky K, Lindner W, Klein W (1992) Stereoselective release of (S)-atenolol from adrenergic nerve endings at exercise. Lancet 340:696-697
12. Egginger G, Lindner W, Brunner F, Stoschitzky K (1994) Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. J Pharm Biomed Anal 12:1537-1545
13. Stoschitzky K, Kahr S, Donnerer J, Schumacher M, Luha O, Maier R, Klein W, Lindner W (1995) Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise. Clin Pharmacol Ther 57:543-551
14. Hurwitz GA, Webb JG, Walle Th, Bai SA, Daniell LG, C Boyd Loadholt, Gaffney TE (1983) Exercise-induced increments in plasma levels of propranolol and noradrenaline. Br J Clin Pharmacol 16:599-608
15. Crumb G (1986) Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems. Biochem Pharmacol 35:1365-1372
16. Arnold JMO, McDevitt DG (1983) Plasma propranolol levels after exercise. Clin Pharmacol Ther 33:247 (B9)
17. Arends BG, Böhm ROB, van Kemenade JE, Rahn KH, van Baak MA (1986) Influence of physical exercise on the pharmacokinetics of propranolol. Eur J Clin Pharmacol 31:375-377
18. Stoschitzky K, Lindner W, Klein W (1994) Chiral aspects of β-adrenoceptor antagonists. Trends Pharmacol Sci 15:102